ALCY: 8-K · proxy statement
Alchemy Investments Acquisition Corp 1 shareholders approved a charter amendment at the September 8, 2026 annual meeting giving the company the right to extend its business combination deadline from September 9, 2026 to September 9, 2027 on a month-to-month basis, as determined by the directors in their sole discretion. Each monthly extension requires a deposit into the trust account at Continental Stock Transfer & Trust Company of the lesser of $30,000 or $0.03 per non-redeemed public Class A ordinary share. The special resolution passed with 3,726,693 shares in favor and 6,412 against, with approximately 93.52% of the 4,208,043 outstanding shares represented at the meeting. Shareholders also ratified CBIZ CPAs P.C. as the independent registered public accounting firm for fiscal year 2026; the company remains a pre-deal SPAC with no announced business combination target.
Alchemy Investments Acquisition Corp 1, a Cayman Islands blank-check company whose units (ALCUF), Class A ordinary shares (ALCYF) and warrants (ALCWF) trade over the counter, adjourned its extraordinary general meeting on September 1, 2026 after shareholders approved the adjournment proposal. The meeting will reconvene on Friday, September 4, 2026 at 10:00 a.m. Eastern Time both at Loeb & Loeb LLP in New York and virtually. In connection with the adjournment, the company is continuing to accept requests from shareholders to reverse previously submitted redemption elections, directing holders to contact their broker or transfer agent Continental Stock Transfer & Trust Company. An adjournment paired with an open redemption-reversal window typically signals that the sponsor is buying time to shore up vote support and reduce redemption pressure ahead of a business combination vote. The filing discloses no vote tallies or redemption amounts, so the key watch items are the September 4 outcome and any disclosed redemption levels.
ALCY: 10-Q · periodic report
Alchemy Investments Acquisition Corp 1 filed its 10-Q for the quarter ended June 30, 2026 with substantial doubt about its ability to continue as a going concern. The SPAC held only $18,995 of cash outside its trust account against a working capital deficit of $4,363,815, while investments held in trust stood at $9,103,236. The company was removed from Nasdaq after failing to complete a business combination within 36 months of its May 4, 2023 IPO effective date. Its securities were suspended from Nasdaq trading on May 14, 2026 and now trade over the counter under ALCUF, ALCYF and ALCWF. Alchemy's pending $540,000,000 merger with Cartiga, LLC must close by September 9, 2026 or the company must liquidate and dissolve. The deal also carries a $40,000,000 minimum closing cash condition, far above the trust balance, meaning closing depends on outside financing or a Cartiga waiver that would trigger tiered sponsor share forfeitures. Second-quarter net loss widened to $307,668 from $220,257 a year earlier, and operations were funded by related-party promissory notes from sponsor Alchemy DeepTech Capital that grew to $2,186,000 at 10% interest.
ALCY: NT 10-Q · late filing
Alchemy Investments Acquisition Corp 1 filed a Form 12b-25 (NT 10-Q) on August 17, 2026, notifying the SEC that it cannot file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 by the prescribed due date. The company offered no specific reason for the delay, citing only that the report could not be filed 'without unreasonable effort or expense,' and said it is working diligently to file the Quarterly Report within five calendar days of the due date. It also stated it does not anticipate any significant change in results of operations versus the corresponding prior-year period, and confirmed all other required periodic reports over the past 12 months were filed on time. The notification was signed by CEO Mattia Tomba. Late quarterly filings by micro-cap SPACs are a warning sign even when a quick cure is expected, so investors should watch for the actual 10-Q within the grace window and any follow-on disclosures such as Nasdaq listing-compliance notices or wind-down plans.
ALCY: DEF 14A · proxy statement
Alchemy Investments Acquisition Corp 1 is soliciting shareholder votes to extend the deadline for completing its initial business combination with Cartiga, LLC from September 9, 2026, to September 9, 2027. The Sponsor, Alchemy DeepTech Capital LLC, has agreed to fund the extension by contributing the lesser of $30,000 or $0.03 per non-redeemed share into the trust account monthly. The company was previously delisted from Nasdaq in May 2026 for failing to consummate a deal within 36 months and currently trades on the OTC market. If approved, public shareholders will retain the right to redeem their shares for approximately $12.41 each, representing their pro rata share of the trust account's $9.15 million balance. The board also recommends ratifying CBIZ CPAs P.C. as the independent auditor for the fiscal year ending December 31, 2026, and approving an adjournment proposal to secure additional votes if necessary. Failure to approve the extension will force the company to liquidate and dissolve the trust account.
ALCY: PRE 14A · proxy statement
Alchemy Investments Acquisition Corp 1 is soliciting shareholder votes to extend the deadline to complete its initial business combination from September 9, 2026, to September 9, 2027. The extension would allow the company additional time to finalize its proposed merger with Cartiga, LLC, which was agreed upon in August 2025. If approved, the sponsor, Alchemy DeepTech Capital LLC, will fund the extension by depositing the lesser of $30,000 or $0.03 per non-redeemed public share into the trust account each month. The company notes that without this extension, it will be forced to cease operations, redeem all public shares, and liquidate. This filing follows a delisting notice from Nasdaq, as the company failed to consummate a deal within the required 36-month window. The company's securities are currently trading on the OTC Pink Open Market under the symbol ALCYF.
ALCY: 25-NSE · delisting
Nasdaq has determined to remove the securities of Alchemy Investments Acquisition Corp 1 from listing, effective at the opening of the trading session on July 20, 2026. The Exchange found the company no longer qualified for listing pursuant to Listing Rule IM-5101-2 based on a review of provided information. The company was notified of this delisting determination on May 7, 2026, and did not appeal the Staff's decision. As a result, the company's securities were suspended on May 14, 2026, and the delisting determination became final on that same date.
Alchemy Investments Acquisition Corp 1 (ALCY) reported a net loss of $331,900 for the three months ended March 31, 2026, citing a material weakness in internal controls over financial reporting related to the accrual of vendor expenses. The company disclosed substantial doubt about its ability to continue as a going concern, with only $86,243 in cash outside its trust account and a working capital deficit of $3.9 million. However, the filing reveals a signed business combination agreement with Cartiga, LLC, valuing the target at $540 million. The transaction involves an Up-C structure where ALCY will domesticate to Delaware and merge with Cartiga, with Melodeon and ASRS retaining significant board influence. The deal requires shareholder approval and has a minimum cash condition of $40 million at closing. The business combination provides a potential exit from the going concern status, but the material weakness in controls and the reliance on related-party promissory notes ($2 million outstanding) present execution risks. The company has extended its deadline to complete a business combination to September 9, 2026.
Alchemy Investments Acquisition Corp 1 filed a Form 12b-25 notification stating it cannot file its 10-Q for the quarter ended March 31, 2026, by the prescribed due date. The company expects to file the report within five calendar days of the deadline, citing unreasonable effort or expense as the reason for the delay. Notably, the filing indicates that not all other required periodic reports from the preceding 12 months have been filed, raising red flags about the company's compliance status.
Alchemy Investments Acquisition Corp. 1 Announces Evaluation of Potential Private Investment in Public Equity to Support Business Combination Transaction with Cartiga
